Merck And Co Inc Drug Patent Portfolio

Merck And Co Inc's Family Patents

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List

Major pharmaceuticals are set to encounter a significant patent expiration wave in 2026 | Drug Discovery News

24 Feb, 2026

Merck plans to establish a distinct division for cancer treatment in anticipation of the impending patent expiration for Keytruda - ET Pharma

24 Feb, 2026

Merck & Co plans to establish an independent cancer division in light of impending patent expirations - The Economic Times

24 Feb, 2026

Merck's Keytruda Expected to Maintain Its Leading Position for Several More Years, Potentially Worth Billions

24 Feb, 2026